{"id":605630,"date":"2026-02-21T10:46:15","date_gmt":"2026-02-21T10:46:15","guid":{"rendered":"https:\/\/www.europesays.com\/us\/605630\/"},"modified":"2026-02-21T10:46:15","modified_gmt":"2026-02-21T10:46:15","slug":"lost-insurance-coverage-for-glp-1-weight-loss-drugs-tell-us","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/605630\/","title":{"rendered":"Lost insurance coverage for GLP-1 weight-loss drugs? Tell us."},"content":{"rendered":"<p class=\"paragraph | gutter_20_0\">With health care spending on wildly popular GLP-1 drugs for weight loss soaring, local insurers got stricter this year on how they would cover the medications. Insurers like <a href=\"https:\/\/www.bostonglobe.com\/2025\/04\/17\/business\/ozempic-blue-cross-blue-shield-weight-loss\/\" target=\"_blank\" rel=\"nofollow noopener\" title=\"https:\/\/www.bostonglobe.com\/2025\/04\/17\/business\/ozempic-blue-cross-blue-shield-weight-loss\/\">Blue Cross Blue Shield of Massachusetts<\/a> and <a href=\"https:\/\/www.bostonglobe.com\/2025\/05\/14\/business\/point32health-weight-loss-glp1-harvard-pilgrim-tufts-health\/\" target=\"_blank\" rel=\"nofollow noopener\" title=\"https:\/\/www.bostonglobe.com\/2025\/05\/14\/business\/point32health-weight-loss-glp1-harvard-pilgrim-tufts-health\/\">Point32Health<\/a> said they would stop covering the drugs for many customers, but have given large employers the option of retaining coverage by paying an extra charge in their health plans.<\/p>\n<p class=\"paragraph | gutter_20_0\">The Globe is looking to talk to Massachusetts residents who were taking GLP-1 drugs to lose weight and are now facing challenges getting their insurers to cover the medication. Did a loss of coverage cause you to stop taking the drugs? Are you paying out of pocket, or buying directly from a manufacturer? We want to hear from you. <\/p>\n<p class=\"paragraph | gutter_20_0\">Fill out the survey below and a reporter may be in touch.<\/p>\n<p class=\"tagline | font_primary inline_block  margin_top_32\">Jonathan Saltzman can be reached at <a href=\"https:\/\/www.bostonglobe.com\/2026\/02\/20\/business\/glp1-weight-loss-drugs-insurance\/mailto:jonathan.saltzman@globe.com\" class=\"\" target=\"_blank\" style=\"font-size:inherit;letter-spacing:.5px\" rel=\"nofollow noopener\">jonathan.saltzman@globe.com<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"With health care spending on wildly popular GLP-1 drugs for weight loss soaring, local insurers got stricter this&hellip;\n","protected":false},"author":3,"featured_media":605631,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[34],"tags":[3992,8015,188966,15210,210,1060,122,47585,56807,188967,1439,47589,67,586,132,68,2969,2742,2402,51921,121957],"class_list":["post-605630","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-americas","tag-american","tag-arranged","tag-drugmakers","tag-health","tag-medication","tag-medicines","tag-north-american","tag-pharmaceutical-drugs","tag-posed","tag-u-s","tag-u-s-a","tag-united-states","tag-united-states-of-america","tag-unitedstates","tag-us","tag-usa","tag-vermont","tag-wegovy","tag-weight-loss-shot","tag-weightloss"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/116108223510968184","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/605630","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=605630"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/605630\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/605631"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=605630"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=605630"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=605630"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}